US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

32.80

-0.2395-0.72%

Volume:171

Turnover:6K

Market Cap:13.12M

PE:- -

High:32.80

Open:33.04

Low:32.80

Close:33.04

52wk High:34.86

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.06

T/O Rate:0.04%

Dividend:0.08

Dividend Rate:0.25%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

ABL Diagnostics Calls Shareholder Vote on Move to Euronext Growth and Name Change

IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed

CSPC Pharma's High-Activity Amylin Receptor Agonist Gets Green Light for Clinical Trials in China

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS

Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

Edwards Lifesciences CVP JAPAC Wayne Markowitz Sells 1,240 Shares for $113,416.60

Globus Medical acquires Higgs Boson Health

Moderna Inc. Stock Falls 5.8%, Underperforms Peers

Gilead Sciences Updates Financial Calendar with Investor Conference Presentations

Roche receives FDA approval for companion diagnostic tests for Ziihera

US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue

THOMSON REUTERS

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

Nike, Merck Share Losses Contribute to Dow's 150-Point Drop

MICOT Pharma's Stroke Drug Completes Mid-Stage Trial in China

IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones

BOAN BIOTECH (06955) Submits IND for BA2201 (TL1A/IL-23) as CDE Accepts Clinical Trial Application

Biogen CFO Robin Kramer to Join Wells Fargo Healthcare Conference Fireside Chat

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/BMED/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":32.8027,"timestamp":1789070400000,"preClose":33.0422,"halted":0,"volume":171,"delay":0,"changeRate":-0.007248306710812222,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.2395,"latestTime":"09-11 09:02:18 EDT","open":33.0422,"high":32.8027,"low":32.8027,"amount":5635,"amplitude":0,"askPrice":52.48,"askSize":200,"bidPrice":15,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":32.8027,"sharesOutstanding":360000,"nav":33.028971,"aum":13211588.4,"dividendRate":0.002518,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.0422,"preClose":32.8027,"latestTime":"16:10 EDT","volume":6,"amount":196.8162,"timestamp":1789071007332,"change":0.2395,"changeRate":0.007301,"amplitude":0},"volumeRatio":0.06156394253025406,"impliedVol":0.2836,"impliedVolPercentile":0.764},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.06156394253025406,"shares":400000,"dividePrice":0.0826,"high":32.8027,"amplitude":0,"preClose":33.0422,"low":32.8027,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":32.8027,"committee":-0.333333,"eps":0,"divideRate":0.002518,"volume":171,"delay":0,"ttmEps":0,"open":33.0422,"prevYearClose":30.32,"prevWeekClose":34.0304,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":34.2802,"twentyDayClose":32.4518,"sixtyDayClose":28.4821},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662084970","title":"ABL Diagnostics Calls Shareholder Vote on Move to Euronext Growth and Name Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084970","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084970?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:37","pubTimestamp":1787848643,"startTime":"0","endTime":"0","summary":"An update from ABL Diagnostics SA ( ($FR:ABLD) ) is now available. ABL Diagnostics SA, a publicly listed French molecular diagnostics group, provid...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-calls-shareholder-vote-on-move-to-euronext-growth-and-name-change?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abl-diagnostics-calls-shareholder-vote-on-move-to-euronext-growth-and-name-change?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HTEC","HELX","BMED","ABLD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195720547","title":"IMMUNEONCO-B Advances Phase II Trial for First-Line Advanced Liver Cancer Therapy With Initial Patient Dosing Completed","url":"https://stock-news.laohu8.com/highlight/detail?id=1195720547","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195720547?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:24","pubTimestamp":1787837055,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has announced that the Phase II clinical trial evaluating IMM2510 (Peravrafusp alfa) in combination with IMM27M (Tazebsumab) as a first-line treatment for patients with advanced...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK4006","COAL","IBBJ","PSYK","HCC","MDTX","BMED","BK1161","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191071495","title":"CSPC Pharma's High-Activity Amylin Receptor Agonist Gets Green Light for Clinical Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1191071495","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191071495?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:30","pubTimestamp":1787826628,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its developed SYH2092 injection has received approval from China's National Medical Products Administration to proceed with clinical trials within the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU1951186391.HKD","LU1226287792.SGD","MDTX","01093","HK0000165453.HKD","IE00B543WZ88.USD","LU1993786604.SGD","LU2039709279.SGD","BK1521","LU0072913022.USD","IE0008369823.USD","LU0501845795.SGD","LU0314109678.HKD","LU1807302812.USD","LU0880133367.SGD","BK1515","LU1960683339.HKD","LU1813983027.USD","LU1226287875.USD","LU1152091754.HKD","LU0315179316.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","PSYK","IBBQ","LU1226288253.USD","LU1152091168.USD","LU0326950275.SGD","LU1226287529.USD","LU0067412154.USD","LU0140636845.USD","IE0008368742.USD","SG9999004220.SGD","LU1226288170.HKD","KURE","BK1191","BMED","LU1008478684.HKD","LU1328277881.USD","IE00B031HY20.USD","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774764","title":"China Approves J&J's Oral Psoriasis Pill, Says Drugmaker","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774764","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774764?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:47","pubTimestamp":1787820442,"startTime":"0","endTime":"0","summary":"China approves J&J's oral psoriasis pill, says drugmakerSHANGHAI, Aug 27 (Reuters)-Johnson & JohnsonJNJ.Nsaid on Thursday that its oral drug icotrokinra was approved in China for moderate-to-severe plaque psoriasis.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O0QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXH","LU1935042991.SGD","BK4534","IE000MB6IJN5.SGD","XLV","TRUH","LU0689472784.USD","LU0820561909.HKD","LU1061106388.HKD","LU1057294990.SGD","IE00BBT3K403.USD","LU0795875169.SGD","LU0162691827.USD","LU2236285917.USD","IHE","LU1244550577.SGD","LU0122379950.USD","FHLC","LU0683600562.USD","LU1228905037.USD","IYH","LU0689626769.HKD","LU1221951046.USD","RXL","IE00BLSP4239.USD","LU0640476718.USD","LU2129689605.HKD","BMED","LU1043141396.HKD","BK4588","IE00BJJMRZ35.SGD","JDOC","LU0426412945.USD","LU1551013342.USD","IE00BGHQF631.EUR","MEDX","VHT","LU1059921491.USD","GDOC","IXJ","LU1732799900.SGD","IE00B19Z3B42.SGD","LU2756315318.SGD","PJP","JNJ","LU0795875086.SGD","IE00BKVL7J92.USD","LU1032955483.USD","LU1162221912.USD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662477411","title":"Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2662477411","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662477411?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:47","pubTimestamp":1787820442,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O0QI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PJP","RXL","LU0943347566.SGD","IE00BN8TJ469.HKD","LU0994945656.USD","IHE","IE0002141913.USD","LU0882574055.USD","VHT","XLV","LU1066051498.USD","LU1196500208.SGD","IE00BVYPNV92.GBP","IE000MB6IJN5.SGD","LU2129689514.USD","FTXH","BK4568","BK4532","JDOC","LU1244550221.USD","LU1244550494.USD","IE0009355771.USD","GDOC","BK4588","BMED","LU2592432038.USD","LU0640476718.USD","LU0053666078.USD","FHLC","IXJ","SG9999001176.USD","LU1551013425.SGD","LU2896262040.SGD","LU1066053197.SGD","LU1894683264.USD","IE00BFXG1179.USD","MEDX","IYH","LU1506573853.SGD","LU1032466523.USD","TRUH","IE00BDGV0183.EUR","IE00BLSP4239.USD","IE00B42XCP33.USD","LU2347655156.SGD","IE0002270589.USD","LU2471134523.USD","IE00BSNM7G36.USD","JNJ","LU2505996681.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187887739","title":"Hong Kong Stock Alert | IMMUNEONCO-B (01541) Surges Nearly 12% as Robust Cash Reserves and Major Clinical Milestones Drive Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1187887739","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187887739?lang=en_us&edition=fundamental","pubTime":"2026-08-27 11:00","pubTimestamp":1787799615,"startTime":"0","endTime":"0","summary":"Shares of IMMUNEONCO-B (01541) jumped nearly 12% during Tuesday trading, last up 10.41% at HK$4.085 with turnover reaching HK$3.429 million.The surge follows the company's interim results released on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","BMED","IBBQ","BK4585","KCAI","BK4588","BK1161","PSYK","01541","IBBJ","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662214687","title":"RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662214687","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662214687?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:45","pubTimestamp":1787795157,"startTime":"0","endTime":"0","summary":"In a report released on August 25, Trung Huynh from RBC Capital maintained a Hold rating on Merck & Company, with a price target of $150.00. The co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-hold-rating-on-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-hold-rating-on-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002224.SGD","BK4007","LU0130517989.USD","LU1201861249.SGD","LU1974910355.USD","SG9999015341.SGD","LU0965509010.AUD","LU1929549753.HKD","LU2491050154.USD","JDOC","LU2023250843.SGD","LU1571399168.USD","HRTS","PPH","LU0289739699.SGD","LU1023059063.AUD","LU1093756168.USD","LU1069347547.HKD","IHE","LU2324357040.USD","RXL","XLV","LU0265550946.USD","LU2360032135.SGD","SG9999014542.SGD","LU1035773651.USD","LU0320765646.SGD","IE00BJT1NW94.SGD","LU0868494708.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU2491050071.SGD","IE00BSNM7G36.USD","LU2357627491.SGD","LU1585245621.USD","LU0985320562.USD","LU1989772923.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","IE00BLSP4452.SGD","LU0006306889.USD","LU0823416689.USD","LU1066051498.USD","LU0124676726.USD","LU1057294990.SGD","LU0238689110.USD","BK4534","LU1941712348.USD","LU2433249047.HKD","LU0648001328.SGD","LU1430594728.SGD","PAWZ","SG9999013999.USD","LU0208291251.USD","LU1917777945.USD","LU2125909593.SGD","FHLC","VHT","LU2491049909.HKD","SG9999014559.SGD","LU2023250504.SGD","LU1066051225.USD","LU0070302665.USD","LU1093756325.SGD","BK4533","BK4585","GDOC","LU1291159041.SGD","IE00BN8TJ469.HKD","FTXH","BMED","LU0859254822.USD","LU0211331839.USD","BK4588","LU2125154935.USD","BK4559","LU1923622614.USD","SG9999001440.SGD","LU0203345920.USD","SG9999014567.USD","SG9999001176.USD","LU1699723380.USD","SGXZ57979304.SGD","IXJ","LU1066051811.HKD","LU0320765489.SGD","LU1941712264.USD","LU1983299246.USD","LU2106854487.HKD","LU0980610538.SGD","SG9999002232.USD","IE0009355771.USD","LU2361044949.HKD","LU0203347892.USD","LU1116320737.USD","SG9999001176.SGD","LU0965509283.SGD","LU2361045086.USD","IE00BBT3K403.USD","LU1934455277.USD","IYH","BK4550","LU0432979614.USD","LU0477156953.USD","LU1037948541.HKD","LU0106261372.USD","LU0234572021.USD","LU0868494617.USD","LU0861579265.USD","LU1934455863.HKD","LU2089984988.USD","IE00BLSP4239.USD","IE00BFTCPJ56.SGD","LU0942090050.USD","LU1989771016.USD","LU2125909247.SGD","SG9999015358.SGD","LU2112291526.USD","IE0002141913.USD","LU0689626769.HKD","SG9999014575.USD","LU2461242641.AUD","LU0098860793.USD","LU0130102774.USD","TRUH","LU0122379950.USD","LU1066053197.SGD","LU0265550359.USD","IE00BJJMRZ35.SGD","LU1162221912.USD","LU0058720904.USD","LU1934455194.USD","LU1037948897.HKD","LU2361044865.SGD","IE00B1BXHZ80.USD","LU0965508806.USD","LU0266013472.USD","BK4516","MRK","LU0965509101.SGD","IE000M9KFDE8.USD","LU2125154778.USD","LU1116320901.HKD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740824","title":"Edwards Lifesciences CVP JAPAC Wayne Markowitz Sells 1,240 Shares for $113,416.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740824","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740824?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:01","pubTimestamp":1787781675,"startTime":"0","endTime":"0","summary":"Edwards Lifesciences CVP JAPAC Wayne Markowitz sells 1,240 shares for $113,416.60Wayne Markowitz, CVP, JAPAC at Edwards Lifesciences, sold 1,240 common shares on Aug. 26, 2026.Sale price USD 91.47 per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL5DN1jQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Edwards Lifesciences CVP JAPAC Wayne Markowitz Sells 1,240 Shares for $113,416.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.SGD","BK4504","LU0058720904.USD","LU0345774391.USD","LU0289739699.SGD","IE00BN0W2W23.USD","BK4567","IHI","LU0823416689.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00BFXG0V08.USD","BK4588","BK4082","IE00BYQQ9H92.USD","SGXZ57979304.SGD","SG9999001176.USD","BMED","EW","BK4585","LU0345774631.USD","AGNG","SG9999013999.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662401907","title":"Globus Medical acquires Higgs Boson Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2662401907","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662401907?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:00","pubTimestamp":1787781613,"startTime":"0","endTime":"0","summary":"Globus Medical (GMED) acquired Higgs Boson Health, a digital healthcare experience company based in Durham, NC and incubated out of Duke University...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/globus-medical-acquires-higgs-boson-health-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/globus-medical-acquires-higgs-boson-health-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IXJ","BMED","IE0009354923.USD","GDOC","BK4550","BK4082","LU2065732104.USD","TCAF","NOBL","EKG","FDHT","VHT","DTEC","CGCV","HEAL","GMED","BK4588","MDTX","HTEC","BK4585","ANEW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662440957","title":"Moderna Inc. Stock Falls 5.8%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662440957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662440957?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:33","pubTimestamp":1787776380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 5.8% to $149.66 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,130.20 and Dow Jones Industrial Average falling 0.2% to 53,463.88.Moderna Inc. closed 15.3% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and Gilead Sciences Inc. fell 0.46% to $148.09.Trading volume totaled 21.8 million, compared to the 50-day average of 16.1 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","GNOM","BBH","TMED","MRNX","MRNY","IBB","MRNA","WDNA","BK4532","LGHT","LU0234570918.USD","BK4533","BK4585","LU0109394709.USD","BIB","IDNA","IE00BZ1G4Q59.USD","LU0965509101.SGD","LU1674673428.USD","LU1674673691.USD","GILD","LU1061106388.HKD","MEDI","TBXU","LU0320765992.SGD","BK4534","LU2324357040.USD","BK4551","LU2087621335.USD","LU1057294990.SGD","LU1934455863.HKD","IBBQ","BK4548","LU0122379950.USD","BMED","LU0861579265.USD","LU1037948541.HKD","LU1839511570.USD","SG9999015978.USD","LU1585245621.USD","LU0058720904.USD","SG9999015952.SGD","LU0965508806.USD","LU1571399168.USD","BK4578","LU0965509283.SGD","IE0002270589.USD","IE00B7SZLL34.SGD","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662417787","title":"Gilead Sciences Updates Financial Calendar with Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2662417787","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662417787?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:05","pubTimestamp":1787774725,"startTime":"0","endTime":"0","summary":"Gilead Sciences updates financial calendar with investor conference presentationsGilead executives will present at the Wells Fargo Annual Healthcare Conference on September 9 at 11:00 a.m. ET.Presenta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL8cjLQm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","LU0859254822.USD","LU1057294990.SGD","TBXU","IE00BKVL7J92.USD","GILD","LU1066053197.SGD","IE00B7SZLL34.SGD","SG9999015952.SGD","IE00B3T34201.USD","LU0965509283.SGD","BIB","BBH","LU1674673428.USD","LU1430594728.SGD","LU1934455277.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU1674673691.USD","LU2112291526.USD","LU0965508806.USD","LU0882574055.USD","BMED","BK4550","BK4568","MEDI","LU1037948541.HKD","LU0122379950.USD","BK4532","IE00B19Z3581.USD","BK4583","LU0861579265.USD","LU1585245621.USD","LU0889565916.HKD","LU2087621335.USD","BK4588","IBBQ","LU1571399168.USD","BK4585","LU0965509010.AUD","LU1066051498.USD","IBB","LU0234570918.USD","LU1778281490.HKD","IE0002270589.USD","TMED","LU0823416689.USD","LU0289739699.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","PINK","HRTS","IYH","BMED","MEDI","BK4588","IDNA","FRTY","RSPH","BBP","IBB","LABU","IEIH","MRNY","CANC","MRNX","03165","RHHBY","TBXU","GNMX","NVIB","BK4585","SYNB","GDOC","LFSC","TECB","BK4007","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746204","title":"US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746204","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662746204?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:57","pubTimestamp":1787767036,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N11D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0124676726.USD","LU2468319806.SGD","PJP","IE00BN8TJ469.HKD","BK4007","LU1032466523.USD","LU0210536198.USD","LU0964807845.USD","LU0234572021.USD","IE00BVYPNW00.USD","LU1989771016.USD","IHE","IYH","IE0002270589.USD","LU1506573853.SGD","LU2456880835.USD","LU0882574055.USD","VHT","LU1074936037.SGD","RXL","LU1280957306.USD","SG9999013999.USD","FTXH","XLV","LU1674673428.USD","MEDX","FHLC","LU0114720955.EUR","LU2896262040.SGD","IE0009355771.USD","IE000SO60NU8.SGD","IE00BGHQF631.EUR","JDOC","LU0994945656.USD","BMED","LU1496350502.SGD","TRUH","LU2129689431.USD","GDOC","BK4504","IXJ","LU2129689605.HKD","LU0943347566.SGD","LU1261432733.SGD","LU0426412945.USD","IE00BLSP4239.USD","LU1057294990.SGD","LU1914381329.SGD","JNJ","LU1221951046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","BBH","PINK","IYH","BK4139","BMED","MEDI","BK4588","IDNA","FRTY","IE00BFTCPJ56.SGD","RSPH","RVMD","LU0320765992.SGD","IE00BJJMRZ35.SGD","BBP","IBB","PTH","IEIH","LABU","MRNY","CANC","MRNX","IE0009354923.USD","LU0889565916.HKD","TBXU","GNMX","IE00BJT1NW94.SGD","IE0002141913.USD","BK4585","NVIB","IE00B2B36J28.USD","SYNB","GDOC","IE00B4R5TH58.HKD","LFSC","TECB","LU0109394709.USD","IE0009355771.USD","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","IYH","GDOC","RVMD","MRNY","BBH","IE00BFTCPJ56.SGD","LFSC","BMED","IE00BJJMRZ35.SGD","MRNX","IE0002141913.USD","IE00B2B36J28.USD","BK4139","CANC","SYNB","RSPH","BBP","TBXU","IE00BJT1NW94.SGD","IDNA","BK4585","NVIB","BK4588","FRTY","XLVX","LABU","PSCH","TECB","LU0320765992.SGD","PINK","IE0009355771.USD","PTH","IBB","IEIH","MEDI","IE0009354923.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662743322","title":"Nike, Merck Share Losses Contribute to Dow's 150-Point Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2662743322","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662743322?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:35","pubTimestamp":1787758500,"startTime":"0","endTime":"0","summary":"DJ Nike, Merck Share Losses Contribute To Dow's 150-Point DropThis article was automatically generated by MarketWatch using technology from Automated Insights.Behind negative returns for shares of Nike and Merck, the Dow Jones Industrial Average is down Wednesday morning.The Dow  was most recently trading 159 points  lower, as shares of Nike  and Merck  are contributing to the blue-chip gauge's intraday decline.Nike's shares have dropped $1.06, or 2.7%, while those of Merck have fallen $2.81 , combining for a roughly 23-point drag on the Dow.Also contributing significantly to the decline are IBM , Goldman Sachs , and Alphabet Inc. Cl A .A $1 move in any of the index's 30 components results in a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","VHT","LU0868494617.USD","MRK","DGRW","PPH","IE000M9KFDE8.USD","DDM","LU2125154778.USD","LU2361044949.HKD","LU0823411888.USD","LU0203345920.USD","LU0211331839.USD","LU0052756011.USD","SG9999015358.SGD","LU1093756325.SGD","LU1917777945.USD","FDN","LU1057294990.SGD","BK4581","LU0265550946.USD","LU0965509283.SGD","LU0859254822.USD","VYM","BK4588","SG9999014567.USD","LU2125909247.SGD","LU0965508806.USD","LU2112291526.USD","SG9999015341.SGD","LU2491049909.HKD","GDOC","LU1267930573.SGD","SDY","SG9999002224.SGD","LU1974910355.USD","LU0823416689.USD","LU0320765489.SGD","BK4516","IE00BLSP4239.USD","LU1066051225.USD","LU0965509101.SGD","TRUH","IXJ","LU2023250843.SGD","SG9999001440.SGD","LU0942090050.USD","DJIA","BMED","LU0792757196.USD","LU1699723380.USD","LU0098860793.USD","SG9999001176.SGD","BK4533","LU0130102774.USD","LU1093756168.USD","LU1934455277.USD","VYMI","IE00BN8TJ469.HKD","BK4146","IE00BFTCPJ56.SGD","LU0868494708.USD","LU0124676726.USD","STYL","LU0106261372.USD","SGXZ57979304.SGD","LU0432979614.USD","IE00B1BXHZ80.USD","LU0266013472.USD","LU1934455863.HKD","VUG","SG9999001176.USD","HRTS","LU1989772923.USD","IE00BJJMRZ35.SGD","LU0889566641.SGD","IE00BSNM7G36.USD","IE0002141913.USD","LU1267930813.SGD","LU1291159041.SGD","PAWZ","LU1023059063.AUD","LU1066053197.SGD","LU1037948541.HKD","LU0310800379.SGD","LU0006306889.USD","LU2361045086.USD","LU1061106388.HKD","LU0128525689.USD","LU1430594728.SGD","LU2360032135.SGD","IE00B4R5TH58.HKD","LU1929549753.HKD","LU1066051498.USD","LU2491050071.SGD","SG9999014542.SGD","BK4550","GRNY","LU1585245621.USD","LU0289739699.SGD","SG9999013999.USD","LU2491050154.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU2106854487.HKD","LU2125154935.USD","SG9999014575.USD","LU0861579265.USD","LU1066051811.HKD","LU2357627491.SGD","SCHD","BK4559","MYMmain","MGK","BK4561","XLV","LU0203347892.USD","BK4585","LU2125909593.SGD","LU0130517989.USD","SDOW","DVY","LU0985320562.USD","LU0238689110.USD","IE0009355771.USD","LU0689626769.HKD","LU1162221912.USD","LU0128525929.USD","RXL","SG9999014559.SGD","LU2468319806.SGD","LU0965509010.AUD","JDOC","BK4534","BK4566","LU0058720904.USD","LU0786609619.USD","LU2461242641.AUD","FTXH","SCHG","DOG","TOPT","XLI","YMAX","IYH","LU2433249047.HKD","LU1983299246.USD","DXD","LU0980610538.SGD","LU1571399168.USD","IHE","LU1035773651.USD","NKE","LU1069347547.HKD","LU2361044865.SGD","LU0029864427.USD","LU2098885051.SGD","FHLC","LU0310800965.SGD",".DJI","LU0208291251.USD","BK4007","BK4558","LU2023250504.SGD","LU0477156953.USD","LU0234572021.USD","LU2324357040.USD","LU1934455194.USD","IE00B2B36J28.USD","LU1201861249.SGD","DJX","LU1989772840.SGD","LU1941712264.USD","IE00BBT3K403.USD","LU1037948897.HKD","DIA","IE00BFXG0V08.USD","LU2089984988.USD","LU1267930227.SGD","LU0070302665.USD","LU1303367103.USD","LU0648001328.SGD","LU1989771016.USD","LU0122379950.USD","LU0265550359.USD","LU0708994859.HKD","DGRO","LU1941712348.USD","LU1116320901.HKD","FDVV","LU1116320737.USD","LU1923622614.USD","SG9999002232.USD","IE00BYQQ9H92.USD","UDOW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114989011","title":"MICOT Pharma's Stroke Drug Completes Mid-Stage Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1114989011","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114989011?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:42","pubTimestamp":1787755330,"startTime":"0","endTime":"0","summary":"MICOT PHARMA-B (02335) has announced the completion of a Phase II clinical trial for its self-developed candidate drug MT200605, designed to treat acute ischemic stroke (AIS).The trial demonstrated...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335","PSYK","IBBJ","BMED","BK1161","IBBQ","AIS","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152821983","title":"IMMUNEONCO-B Reports Interim Results with RMB 25.4 Million Revenue and Key Clinical Trial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=1152821983","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152821983?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:56","pubTimestamp":1787752576,"startTime":"0","endTime":"0","summary":"IMMUNEONCO-B (01541) has released its interim results for the six months ended June 30, 2026, reporting revenue of RMB 25.424 million. Research and development expenses totaled RMB 155 million,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1161","PSYK","MDTX","BMED","IBBJ","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159273287","title":"BOAN BIOTECH (06955) Submits IND for BA2201 (TL1A/IL-23) as CDE Accepts Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1159273287","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159273287?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:14","pubTimestamp":1787742861,"startTime":"0","endTime":"0","summary":"BOAN BIOTECH has announced that its investigational new drug (IND) application for BA2201 has been accepted for review by the Center for Drug Evaluation (CDE) of China's National Medical Products...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1161","06955","SIL","PSYK","BK4017","IBBJ","GDXJ","BMED","LU1223082519.USD","MDTX","SGDM","LU1223083913.SGD","CDE","XME","LU1223082196.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662184267","title":"Biogen CFO Robin Kramer to Join Wells Fargo Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662184267","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662184267?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:59","pubTimestamp":1787741942,"startTime":"0","endTime":"0","summary":"Biogen CFO Robin Kramer to join Wells Fargo Healthcare Conference fireside chatBiogen will join a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Sept. 9, 2026 at 9:30 a.m. ET.Pa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL9qnkfK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE00B19Z9Z06.USD","BK4588","BMED","BK4585","IE00B894F039.SGD","LU0320765992.SGD","PBE","BIIB","LU0889565916.HKD","BK4532","LU0109394709.USD","LU0234570918.USD","BK4139","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}